Explore more publications!
Health Digest Cook Islands
Got News to Share?

Health Digest Cook Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Digest Cook Islands.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 15, 2025

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
December 15, 2025

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

Indeterminate GlobeNewswire
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
December 15, 2025

Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST

Indeterminate GlobeNewswire
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 15, 2025

XOMA Royalty Enters into Agreement to Acquire Generation Bio

Indeterminate GlobeNewswire
Cellectis Announces Arbitral Decision in Dispute with Servier
December 15, 2025

Cellectis Announces Arbitral Decision in Dispute with Servier

Indeterminate GlobeNewswire
BioSyent Announces Renewal of Normal Course Issuer Bid
December 15, 2025

BioSyent Announces Renewal of Normal Course Issuer Bid

Indeterminate GlobeNewswire
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
December 15, 2025

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Indeterminate GlobeNewswire
Abivax Presents Third Quarter 2025 Financial Results
December 15, 2025

Abivax Presents Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 15, 2025

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

Indeterminate GlobeNewswire
FHSU’s Hybrid BSN Program expands access to nursing education
December 15, 2025

FHSU’s Hybrid BSN Program expands access to nursing education

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
December 15, 2025

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
December 15, 2025

AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers

Indeterminate GlobeNewswire
AB Science annonce une nouvelle publication sur biorxiv identifiant AB8939 comme un candidat médicament prometteur pour le traitement de la leucémie myéloïde aiguë réfractaire et potentiellement d'autres cancers
December 15, 2025

AB Science annonce une nouvelle publication sur biorxiv identifiant AB8939 comme un candidat médicament prometteur pour le traitement de la leucémie myéloïde aiguë réfractaire et potentiellement d'autres cancers

Indeterminate GlobeNewswire
Booking Health Releases 2026 Rankings of Germany’s Most Trusted Cancer Hospitals for International Patients
December 15, 2025

Booking Health Releases 2026 Rankings of Germany’s Most Trusted Cancer Hospitals for International Patients

Indeterminate GlobeNewswire
U.S. Court of Appeals Affirms Novarad’s ’807 Patent as Company Continues to Defend Leadership in Augmented Reality Surgical Navigation
December 15, 2025

U.S. Court of Appeals Affirms Novarad’s ’807 Patent as Company Continues to Defend Leadership in Augmented Reality Surgical Navigation

Indeterminate GlobeNewswire
New research in ONCOLOGY® identifies gaps between gynecologic cancer disease burden and clinical trial availability at UCLA Jonsson Comprehensive Cancer Center
December 15, 2025

New research in ONCOLOGY® identifies gaps between gynecologic cancer disease burden and clinical trial availability at UCLA Jonsson Comprehensive Cancer Center

Indeterminate GlobeNewswire
BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
December 15, 2025

BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

Indeterminate GlobeNewswire
NeOnc Technologies Reports Updated Clinical Results
December 15, 2025

NeOnc Technologies Reports Updated Clinical Results

Indeterminate GlobeNewswire
Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma
December 15, 2025

Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma

Indeterminate GlobeNewswire
Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease
December 15, 2025

Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease

Indeterminate GlobeNewswire
ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting
December 15, 2025

ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions